Akso Health Group income statement

In fiscal 2026, Akso Health Group reported revenue of $13.8m, down 6.4% on the year before, operating income of −$20.7m (a -149.7% margin) and net income of −$18.7m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Akso Health Group: income statement, annual
Fiscal year	2017Mar 2017	2018Mar 2018	2019Mar 2019	2020Mar 2020	2021Mar 2021	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Revenue	23	107	83	7	2	6	13	2	15	14
Cost of revenue	5	8	7	1	1	5	12	2	15	14
Gross profit	23	107	75	7	2	1	1	0	−0	−0
Research and development	2	3	0	0	0	0	—	—	—	—
Selling, general and administrative	—	—	—	—	—	—	—	9	4	4
Selling and marketing	5	15	1	1	1	0	0	—	—	—
General and administrative	3	6	3	20	2	3	16	—	—	—
Operating income	10	76	−7	−48	−4	−3	−14	−9	−166	−21
Interest expense	—	—	—	—	2	1	—	—	—	—
Net interest income	—	1	—	—	—	—	—	—	—	—
Provision for credit losses	—	—	1	14	22	6	—	—	—	—
Income before tax	10	77	−7	−47	−4	−4	−13	−9	−166	−21
Income tax	2	11	1	0	0	0	0	0	−31	−2
Net income	9	65	6	−71	−35	−17	−1	−9	−135	−19
Diluted EPS	$0.30	$2.06	$0.15	−$2.19	−$1.06	−$0.42	−$0.03	—	—	—
Diluted shares (average)	28m	32m	35m	33m	33m	40m	46m	47m	285m	723m
EBITDA	10	76	−7	−48	−4	−3	—	—	−164	−18

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AHG vs AMS AHG vs CCEL AHG vs HAO

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Akso Health Group's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Akso Health Group.